Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
McKesson
Merck
Harvard Business School
Mallinckrodt

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Litigation Details for ABBOTT LABORATORIES v. WATSON LABORATORIES, INC.-FLORIDA (D.N.J. 2010)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

ABBOTT LABORATORIES v. WATSON LABORATORIES, INC.-FLORIDA (D.N.J. 2010)

Docket   Start Trial Date Filed 2010-04-27
Court District Court, D. New Jersey Date Terminated 2012-06-12
Cause 35:271 Patent Infringement Assigned To Dennis M. Cavanaugh
Jury Demand None Referred To Magistrate Judge Joseph A. Dic
Parties ABBOTT LABORATORIES; FOURNIER LABORATORIES IRELAND LTD.; WATSON LABORATORIES, INC.-FLORIDA; WATSON PHARMA, INC.; WATSON PHARMACEUTICALS, INC.
Patents 7,259,186
Attorneys CHAD JOHNSON PETERMAN; EDWARD RICHARD TEMPESTA; GEORGE C. JONES; GERALD KROVATIN; LIZA M. WALSH; MICHAEL F. BUCHANAN; RUKHSANAH L. SINGH; TARA LYNN MERCADANTE; THOMAS R. CURTIN
Firms Jackson Lewis Pc; Patterson Belknap Webb & Tyler LLP
Link to Docket External link to docket
Small Molecule Drugs cited in ABBOTT LABORATORIES v. WATSON LABORATORIES, INC.-FLORIDA
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for ABBOTT LABORATORIES v. WATSON LABORATORIES, INC.-FLORIDA (D.N.J. 2010)

Date Filed Document No. Description Snippet Link To Document
2012-06-04 106 pharmaceutical patent infringement suit. Plaintiffs jointly own the rights to U.S. Patent No. 7.259,186 (the “…always, disagreed on whether the Krause patent renders the ’186 Patent obvious. 6 Case 2'10-cv…regarding the Krause patent and did not change his ultimate opinion that the Krause patent does not anticipate… “’186 Patent”), which currently expires on January 7, 2025, and claims novel salts of and formulations…Plaintiffs thereafter filed the present suit for patent infringement Ia’. at. 1111 25-31. On July 15, External link to document
2011-10-24 74 Judgment by Defendants That Claims 1-2 of U.S. Patent No. 7,259,186 Are Invalid by WATSON LABORATORIES, INC.… 12 June 2012 2:10-cv-02139-DMC-JAD Patent None District Court, D. New Jersey External link to document
2011-10-24 75 Summary Judgment That Claims 1-2 of U.S. Patent No. 7,259,186 Are Invalid (CONFIDENTIAL, Filed Under Seal… 12 June 2012 2:10-cv-02139-DMC-JAD Patent None District Court, D. New Jersey External link to document
2011-11-02 76 Judgment by Defendants That Claims 1-2 of U.S. Patent No. 7,259,186 Are Invalid filed by ABBOTT LABORATORIES… 12 June 2012 2:10-cv-02139-DMC-JAD Patent None District Court, D. New Jersey External link to document
2011-11-21 77 Judgment by Defendants That Claims 1-2 of U.S. Patent No. 7,259,186 Are Invalid. (Attachments: # 1 Text of Proposed… 12 June 2012 2:10-cv-02139-DMC-JAD Patent None District Court, D. New Jersey External link to document
2011-11-22 78 Judgment by Defendants That Claims 1-2 of U.S. Patent No. 7,259,186 Are Invalid [Public Version - Redacted] … 12 June 2012 2:10-cv-02139-DMC-JAD Patent None District Court, D. New Jersey External link to document
2011-11-22 79 Judgment by Defendants That Claims 1-2 of U.S. Patent No. 7,259,186 Are Invalid [Unredacted Version - Subject… 12 June 2012 2:10-cv-02139-DMC-JAD Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
McKinsey
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.